Business
Novo Nordisk Reports Promising Trial Results for Next-Gen Obesity Drug, Shares Surge
Novo Nordisk, Europe’s largest pharmaceutical company, announced encouraging trial results for its next-generation obesity drug, amycretin, propelling its shares to a 7.13% gain in Copenhagen on Friday.
Key Trial Findings
The trial revealed that patients on the highest dose of 20 milligrams of amycretin achieved an estimated weight loss of 22% over 36 weeks. This result closely rivals Eli Lilly’s obesity drug Zepbound, which achieved a 22.5% weight loss over 72 weeks, and Lilly’s next-generation treatment, retatrutide, which reported a 24.4% weight reduction over 48 weeks.
Novo Nordisk’s amycretin is seen as a major contender in the competitive weight-loss drug market, particularly as the patent for its blockbuster treatment Wegovy is set to expire in the early 2030s.
Advancements in Treatment
Amycretin represents a significant step forward in weight-loss therapies, combining the effects of two hormones, glucagon-like peptide-1 (GLP-1) and amylin. This dual action enhances satiety and regulates blood sugar levels, providing a more comprehensive approach compared to Wegovy, which focuses solely on GLP-1.
The trials tested once-weekly injections of amycretin in 125 participants, showing:
- 9.7% weight loss with a 1.25-milligram dose over 20 weeks.
- 16.2% weight loss with 5 milligrams over 28 weeks.
- 22.1% weight loss with 20 milligrams over 36 weeks.
Most side effects were gastrointestinal and mild to moderate in severity. Novo Nordisk plans to advance amycretin into further clinical trials for adults with obesity or overweight conditions.
Market Impact and Competition
Following the announcement, Novo Nordisk’s shares saw a significant surge, recovering from a 14% decline over the past year. Meanwhile, Eli Lilly, a key competitor, experienced a brief 1.2% dip in U.S. markets before closing 2.45% higher.
Eli Lilly is also making strides with its oral weight-loss pill, orforglipron, which demonstrated a 14.7% weight loss over 36 weeks in a mid-stage trial. Oral treatments are gaining traction due to their convenience and cost-effectiveness compared to injectable therapies.
Novo Nordisk is developing an oral version of amycretin, showing a 13.1% weight reduction in trials, although this formulation presented more side effects. Its oral semaglutide trials reported a 15% weight loss over 68 weeks.
Outlook
With amycretin’s promising results and Wegovy’s robust sales, which rose 79% year-on-year in Q3, Novo Nordisk is poised for growth in the weight-loss drug market. The company’s fourth-quarter and full-year earnings are set to be released on February 5, offering further insights into its performance amid intensifying competition.
Business
Iran Conflict Sparks Global Fertiliser Crunch, Raising Fears for Food Security
The war involving Iran and the continued blockade of the Strait of Hormuz are beginning to ripple through global agriculture, with rising fertiliser costs threatening food production and pushing farmers under increasing financial strain.
A new World Bank report warns that soaring energy prices and disrupted trade routes have created a severe fertiliser squeeze, driving affordability for farmers to its lowest level in four years. The crisis is being fuelled largely by a sharp rise in natural gas prices, a key ingredient in the production of nitrogen-based fertilisers.
Because fertiliser production is closely tied to energy markets, any spike in gas prices quickly translates into higher costs for farmers. That dynamic is now raising concerns about the impact on future harvests, particularly in regions already facing economic and food security challenges.
European agriculture ministers are reportedly discussing emergency measures to shield farmers from escalating costs and to protect grain production for next year. While Europe is not currently facing an immediate supply shortage, industry groups say the pressure on farm finances is intensifying.
A spokesperson for Fertilisers Europe said the continent remains relatively well supplied, thanks to strong domestic production and high import levels in recent months. Europe typically meets around 70% of its fertiliser demand through its own output.
However, the organisation warned that farmers are operating on increasingly narrow margins. It called for targeted support from European Union institutions while also ensuring that assistance does not undermine the competitiveness of the region’s fertiliser industry.
The situation is more severe outside Europe. According to the UN Food and Agriculture Organization, shipping disruptions through the Strait of Hormuz have caused significant fertiliser shortages across Asia, the Middle East and parts of Africa.
Countries including India, Bangladesh, Sri Lanka, Egypt, Sudan and several nations in sub-Saharan Africa are facing rising costs, reduced availability and growing risks to food security.
Analysts warn that if farmers cut fertiliser use to save money, crop yields could fall sharply in the next planting season. Research from the International Food Policy Research Institute suggests that reduced application rates would likely lower global grain production and tighten food supplies.
The FAO’s Food Price Index has already begun to rise, reflecting mounting concerns over input costs and supply disruptions. Higher transport expenses and logistical challenges linked to the conflict are expected to place additional upward pressure on food prices in the months ahead.
For many developing economies already struggling with inflation, the impact could be especially severe. Policymakers may face difficult choices as they seek to balance economic stability with food affordability.
Experts say the crisis underscores the importance of securing not only food supplies, but also the essential inputs that make food production possible. Without a stabilisation of energy markets and a restoration of normal shipping routes, the effects of the Iran conflict could linger far beyond the battlefield.
Business
Oil Markets Jolt as UAE Exits OPEC Amid Strait of Hormuz Crisis
Business
UAE’s OPEC Exit Marks New Chapter for Gulf Energy Strategy
-
Entertainment2 years agoMeta Acquires Tilda Swinton VR Doc ‘Impulse: Playing With Reality’
-
Business2 years agoSaudi Arabia’s Model for Sustainable Aviation Practices
-
Business2 years agoRecent Developments in Small Business Taxes
-
Sports2 years agoChina’s Historic Olympic Victory Sparks National Pride Amid Controversy
-
Home Improvement1 year agoEffective Drain Cleaning: A Key to a Healthy Plumbing System
-
Politics2 years agoWho was Ebrahim Raisi and his status in Iranian Politics?
-
Sports2 years agoKeely Hodgkinson Wins Britain’s First Athletics Gold at Paris Olympics in 800m
-
Business2 years agoCarrectly: Revolutionizing Car Care in Chicago
